Welcome to our dedicated page for Cosmos Health news (Ticker: COSM), a resource for investors and traders seeking the latest updates and insights on Cosmos Health stock.
Cosmos Health Inc. (NASDAQ:COSM) is a vertically integrated global healthcare leader specializing in nutraceuticals, pharmaceuticals, and telehealth solutions. This page provides investors and industry stakeholders with timely updates on corporate developments, financial performance, and strategic initiatives driving innovation in healthcare.
Access authoritative coverage of COSM's earnings announcements, regulatory milestones, product launches, and partnership agreements. Our curated news collection simplifies tracking the company's progress across its core segments: proprietary nutraceutical brands like Sky Premium Life®, pharmaceutical manufacturing, and AI-driven R&D advancements.
Discover how Cosmos Health leverages its global distribution network and telehealth platform to address evolving healthcare needs. Bookmark this page for direct access to press releases and market-moving updates, ensuring you stay informed about COSM's role in shaping the future of wellness and medical innovation.
Cosmos Health Inc. (NASDAQ:COSM) announced its fiscal year 2022 results, reporting revenues of $50.3 million, a decline from $56.2 million in FY2021 primarily due to foreign exchange variations. However, on a constant currency basis, revenue growth was noted at 0.71%. The company achieved positive Adjusted EBITDA of $0.5 million and significantly improved its financial position, ending 2022 with approximately $21 million in cash and long-term debt reduced by 76% to $5.1 million. Cosmos raised $56.5 million from equity offerings and warrant exercises. Amid market challenges, the CEO praised the company's strong performance and outlined plans for growth through acquisitions, including Cana Laboratories and ZipDoctor, enhancing the company’s vertical integration and entry into telehealth.
Cosmos Health (Nasdaq:COSM) announced its participation in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, at the Lotte Palace, New York. CEO Greg Siokas will deliver a speech, partake in a Q&A, and engage in discussions about investment opportunities in the Eastern Mediterranean. The summit aims to explore the region's business potential with prominent speakers from the US, Israel, Greece, and Cyprus. Attendees include executives from various industries and institutional investors. This event highlights Cosmos Health's commitment to innovation, product development, and international expansion.
FAQ
What is the current stock price of Cosmos Health (COSM)?
What is the market cap of Cosmos Health (COSM)?
